老年癌症药理学 - Suppr

Suppr

超能文献

Cancer pharmacology in the elderly.

作者信息

Egorin M J

机构信息

Division of Developmental Therapeutics, University of Maryland Cancer Center, Baltimore 21201.

出版信息

Semin Oncol. 1993 Feb;20(1):43-9.

PMID:8475409

Abstract

摘要

相似文献

Cancer pharmacology in the elderly.老年癌症药理学

Semin Oncol. 1993 Feb;20(1):43-9.

Pharmacology of antineoplastic agents in the elderly patient.老年患者抗肿瘤药物的药理学

Semin Oncol. 1989 Feb;16(1):76-84.

[Cancer chemotherapy in patients older than 75 years old--from the aspect of clinical pharmacology].[75岁以上患者的癌症化疗——从临床药理学角度探讨]

Gan To Kagaku Ryoho. 1998 Jun;25(7):995-9.

Clinical pharmacology issues relevant to the dosing and toxicity of chemotherapy drugs in the elderly.与老年患者化疗药物剂量及毒性相关的临床药理学问题。

Oncologist. 2005 Sep;10(8):602-12. doi: 10.1634/theoncologist.10-8-602.

Individualizing dosing of cancer chemotherapy.癌症化疗的个体化给药

Semin Oncol. 1993 Feb;20(1):30-42.

[Pharmacology of anticancer drugs in the elderly: tools for dose-adjustment].[老年患者抗癌药物药理学：剂量调整工具]

Bull Cancer. 2008 May 28;95 FMC Onco:F21-7. doi: 10.1684/bdc.2007.0541.

Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.蛋白酶体抑制剂硼替佐米用于晚期实体瘤患者的I期试验及对雄激素非依赖性前列腺癌的观察

J Clin Oncol. 2004 Jun 1;22(11):2108-21. doi: 10.1200/JCO.2004.02.106.

[Pharmacokinetically guided dose-escalation (PGDE) strategy].[药代动力学指导的剂量递增（PGDE）策略]

Gan To Kagaku Ryoho. 2000 Jul;27(7):1069-74.

Pharmacology of antineoplastic medications in older cancer patients.老年癌症患者抗肿瘤药物的药理学

Oncology (Williston Park). 2009 Jan;23(1):78-85.

Dose adjustment and supportive care before and during treatment.治疗前及治疗期间的剂量调整与支持性护理。

Cancer Treat Rev. 2009 Oct;35(6):493-8. doi: 10.1016/j.ctrv.2009.04.009. Epub 2009 Jun 2.

引用本文的文献

Pharmacokinetics of intravenous busulfan as condition for hematopoietic stem cell transplantation: comparison between combinations with cyclophosphamide and fludarabine.静脉注射白消安的药代动力学作为造血干细胞移植的条件：与环磷酰胺和氟达拉滨联合应用的比较。

Int J Hematol. 2021 Jan;113(1):128-133. doi: 10.1007/s12185-020-02990-y. Epub 2020 Sep 4.

Real-world evidence on adjuvant chemotherapy in older adults with stage II/III colon cancer.老年II/III期结肠癌患者辅助化疗的真实世界证据。

World J Gastrointest Oncol. 2020 Jun 15;12(6):604-618. doi: 10.4251/wjgo.v12.i6.604.

Prognostic impact of breast cancer subtypes in elderly patients.老年患者中乳腺癌亚型的预后影响

Breast Cancer Res Treat. 2016 May;157(1):91-9. doi: 10.1007/s10549-016-3787-y. Epub 2016 Apr 23.

Effect of Renal Dysfunction on Toxicity in Three Decades of Cancer Therapy Evaluation Program-Sponsored Single-Agent Phase I Studies.肾功能不全对癌症治疗评估项目资助的单药I期研究三十年毒性的影响。

J Clin Oncol. 2016 Jan 10;34(2):110-6. doi: 10.1200/JCO.2014.59.7302. Epub 2015 Sep 21.

Effect of age on the pharmacokinetics of busulfan in patients undergoing hematopoietic cell transplantation; an alliance study (CALGB 10503, 19808, and 100103).年龄对接受造血细胞移植患者中白消安药代动力学的影响；一项联盟研究（CALGB 10503、19808和100103）

Cancer Chemother Pharmacol. 2014 Nov;74(5):927-38. doi: 10.1007/s00280-014-2571-0. Epub 2014 Aug 28.

[Comorbidity oriented oncology - an overview].[以合并症为导向的肿瘤学——综述]

Wien Klin Wochenschr. 2010 Apr;122(7-8):203-18. doi: 10.1007/s00508-010-1363-8.

Non-Hodgkin's lymphoma in the elderly.老年人非霍奇金淋巴瘤。

Drugs Aging. 2010 Mar 1;27(3):211-38. doi: 10.2165/11531550-000000000-00000.

Oral anticancer drugs in the elderly: an overview.老年患者的口服抗癌药物：概述

Drugs Aging. 2007;24(5):395-410. doi: 10.2165/00002512-200724050-00004.

Pharmacology of anticancer drugs in the elderly population.老年人群中抗癌药物的药理学

Clin Pharmacokinet. 2003;42(14):1213-42. doi: 10.2165/00003088-200342140-00003.

Pharmacological factors influencing anticancer drug selection in the elderly.影响老年人抗癌药物选择的药理学因素。

Drugs Aging. 2003;20(10):737-59. doi: 10.2165/00002512-200320100-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验